Susquehanna International Group
BBP icon

Susquehanna International Group’s Virtus Biotech ETF BBP Stock Holding History

Susquehanna International Group’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
10,777
-23,075
-68% -$2.01M ﹤0.01% 8108
2026
Q1 		$2.81M Buy
33,852
+27,817
+461% +$2.29M ﹤0.01% 5398
2025
Q4 		$482K Sell
6,035
-22,925
-79% -$1.74M ﹤0.01% 8873
2025
Q3 		$2.03M Buy
28,960
+457
+2% +$29.9K ﹤0.01% 5773
2025
Q2 		$1.66M Buy
+28,503
New +$1.61M ﹤0.01% 6194
2025
Q1 		– Sell
-4,902
Closed -$294K – 12469
2024
Q4 		$294K Sell
4,902
-2,002
-29% -$127K ﹤0.01% 9876
2024
Q3 		$434K Sell
6,904
-1,473
-18% -$91.7K ﹤0.01% 8800
2024
Q2 		$492K Buy
8,377
+747
+10% +$41.6K ﹤0.01% 8308
2024
Q1 		$432K Sell
7,630
-9,265
-55% -$540K ﹤0.01% 8868
2023
Q4 		$981K Buy
16,895
+4,133
+32% +$209K ﹤0.01% 7037
2023
Q3 		$639K Buy
12,762
+2,033
+19% +$107K ﹤0.01% 7665
2023
Q2 		$565K Sell
10,729
-2,030
-16% -$107K ﹤0.01% 8037
2023
Q1 		$629K Sell
12,759
-295
-2% -$14.8K ﹤0.01% 8008
2022
Q4 		$643K Sell
13,054
-1,155
-8% -$55.3K ﹤0.01% 7218
2022
Q3 		$644K Sell
14,209
-1,781
-11% -$82.2K ﹤0.01% 7782
2022
Q2 		$659K Buy
15,990
+2,170
+16% +$86.2K ﹤0.01% 7589
2022
Q1 		$601K Sell
13,820
-2,742
-17% -$118K ﹤0.01% 8483
2021
Q4 		$809K Buy
16,562
+11,578
+232% +$575K ﹤0.01% 7849
2021
Q3 		$254K Buy
4,984
+484
+11% +$25K ﹤0.01% 10974
2021
Q2 		$240K Buy
+4,500
New +$237K ﹤0.01% 11220
2020
Q1 		– Sell
-4,989
Closed -$217K – 10212
2019
Q4 		$217K Buy
+4,989
New +$200K ﹤0.01% 8624
2019
Q3 		– Sell
-5,628
Closed -$231K – 10140
2019
Q2 		$231K Buy
+5,628
New +$232K ﹤0.01% 8839
2018
Q2 		– Sell
-30,466
Closed -$1.26M – 9591
2018
Q1 		$1.26M Buy
30,466
+3,003
+11% +$126K ﹤0.01% 4769
2017
Q4 		$1.11M Sell
27,463
-14
-0.1% -$559 ﹤0.01% 5011
2017
Q3 		$1.14M Buy
27,477
+1,461
+6% +$58.4K ﹤0.01% 5037
2017
Q2 		$1.03M Buy
+26,016
New +$972K ﹤0.01% 5204
2016
Q4 		– Sell
-28,485
Closed -$950K – 9553
2016
Q3 		$950K Sell
28,485
-19,162
-40% -$592K ﹤0.01% 4909
2016
Q2 		$1.28M Buy
47,647
+3,998
+9% +$106K ﹤0.01% 4349
2016
Q1 		$1.08M Buy
43,649
+19,221
+79% +$468K ﹤0.01% 4932
2015
Q4 		$753K Buy
24,428
+2,721
+13% +$82.4K ﹤0.01% 5993
2015
Q3 		$599K Buy
21,707
+12,627
+139% +$426K ﹤0.01% 6766
2015
Q2 		$319K Buy
+9,080
New +$298K ﹤0.01% 8427

Other funds holding BBP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $403M AUM 42.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Susquehanna International Group's BBP Position: Q2 2026 in Review

Susquehanna International Group reduced its Virtus Biotech ETF (BBP) stake by 68% in Q2 2026, selling an estimated $2.01M and leaving 10,777 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #8108.

Susquehanna International Group first reported a position in BBP in Q2 2015 and has held it in 32 quarters since. The position peaked at $2.81M in Q1 2026. 26 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

  • Susquehanna International Group held 10,777 shares of Virtus Biotech ETF worth $1.04M as of Q2 2026.
  • Susquehanna International Group sold 23,075 Virtus Biotech ETF shares in Q2 2026, an estimated $2.01M.
  • Virtus Biotech ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #8108 holding.
  • Susquehanna International Group first reported a position in Virtus Biotech ETF in Q2 2015 and has held it in 32 quarters since.
  • Susquehanna International Group's Virtus Biotech ETF position peaked at $2.81M in Q1 2026.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.